SKIN

SkinHealth Systems Inc.
—

Company Information

Company Name
SkinHealth Systems Inc.
CIK
CIK0001818093
Category
Accelerated filer
Ticker: Exchange
SKIN: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
SKIN

SEC filing data through

Insider Sentiment

Last purchase
2024-08-12
Last sale
2024-11-20
Shares purchased (TTM)
40,450
Shares sold (TTM)
14,663
Buy ratio (TTM)73.4%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
67,035,961
Shares outstanding
129,596,886
Ownership
51.73%
-7.04% Y/Y

Earnings Market Reaction

Filing date
2026-08-06
Price on filing date
—
1-month reaction
-10.81%
3-month reaction
…
Drift continued5/11 (45%)
Faded / reversed6/11 (55%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value206204233219212373370359350445523559
Accounts Receivable Net Current181922222523283641485567
Inventory Net474848565966697377969175
Income Taxes Receivable222320100101
Prepaid Expense And Other Assets Current235578791621262936
Assets Current295278310308306469477485490615698738
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization2233446810121416
Operating Lease Right Of Use Asset192012141212141515161213
Finite Lived Intangible Assets Net303336384346485154586265
Goodwill126126127126126124123125125125126125
Deferred Income Tax Assets Net222134413211
Other Assets Noncurrent111112131314141516161616
Assets487473500504508674686700712845929973
Liabilities Current
Convertible Debt Current103103124---0-----
Accounts Payable Current161616172323222327374536
Employee Related Liabilities Current131325191515181717152221
Operating Lease Liability Current445555554555
Accrued Income Taxes Current001133312332
Accrued Liabilities Current321915191417202824242030
Liabilities Current16815518662596368747594115126
Operating Lease Liability Noncurrent181991181011121314910
Deferred Income Tax Liabilities Net000000011112
Warrants And Rights Outstanding---000011547
Convertible Debt Noncurrent242241240363363553552551551665738737
Other Liabilities Noncurrent222222212330
Liabilities431418439438434628634640643781870883
Stockholders Equity
Common Stock Value000000000000
Additional Paid In Capital584581580577575570567561553547541565
Accumulated Other Comprehensive Income Loss Net Of Tax-1-2-1-2-2-6-7-4-5-4-3-5
Retained Earnings Accumulated Deficit-527-524-517-509-498-518-508-498-479-480-479-469
Stockholders Equity565561667446526069635990
Liabilities And Stockholders Equity487473500504508674686700712845929973
Allowance For Doubtful Accounts Receivable Current45678910118775
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized320320320320320320320320320320320320
Common Stock Shares Issued130129128127127125125124124123123133
Shares Outstanding130129128127127125125124124123123133

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

SkinHealth Systems Inc. (SKIN) — SEC Financial Statements & Analysis

SkinHealth Systems Inc. (SKIN) is a surgical & medical instruments & apparatus company, incorporated in DE. SkinHealth Systems Inc. trades on Nasdaq as: SKIN. SkinHealth Systems Inc. (SKIN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, SkinHealth Systems Inc. carries a market cap of $89.81M, a P/E ratio of -3.16x, a P/B ratio of 1.62x, a P/S ratio of 0.31x, an enterprise value of $228.95M, and an EV/EBITDA multiple of -118.26x. On profitability, it posts a gross margin of 66.35%, an operating margin of -1.49%, a net margin of -9.80%, a Return on Equity (ROE) of -43.89%, a Return on Assets (ROA) of -5.72%, and a Return on Invested Capital (ROIC) of -2.00%. Per share, it reports EPS of $-0.22, diluted EPS of $-0.22, free cash flow per share of $0.16, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -6.46% year-over-year, net income growth of 49.61% year-over-year, and EPS growth of 45.54% year-over-year. On the balance sheet, it maintains a current ratio of 1.76x, a quick ratio of 1.34x, working capital of $127.04M, a debt-to-equity ratio of 7.76x, a debt ratio of 0.89, an interest coverage ratio of -0.17x, free cash flow of $21.14M (TTM), and net debt of $139.13M. Figures sourced from SEC EDGAR.

Market Cap
$89.81M
P/E TTM
-3.16x
EPS TTM
$-0.22
P/B TTM
1.62x
ROE TTM
-43.89%
ROA TTM
-5.72%
Debt To Equity
7.76x
Free Cash Flow TTM
$21.14M
Net Revenue TTM Growth 1Y
-6.46%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SkinHealth Systems Inc. in?

SkinHealth Systems Inc. (SKIN) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does SKIN trade on?

SkinHealth Systems Inc. (SKIN) trades on the Nasdaq.

Where is SkinHealth Systems Inc. incorporated?

SkinHealth Systems Inc. is incorporated in DE.

When was SkinHealth Systems Inc. (SKIN)'s most recent SEC filing?

SkinHealth Systems Inc. (SKIN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.

What is SKIN's market cap?

SkinHealth Systems Inc. (SKIN) has a market capitalization of $89.81M as of 2026-06-30.

What is SKIN's EPS (earnings per share)?

SkinHealth Systems Inc. (SKIN)'s trailing twelve month EPS is $-0.22 as of 2026-06-30.

What is SKIN's ROE (return on equity)?

SkinHealth Systems Inc. (SKIN)'s trailing twelve month Return on Equity (ROE) is -43.89% as of 2026-06-30.

What is SKIN's ROA (return on assets)?

SkinHealth Systems Inc. (SKIN)'s trailing twelve month Return on Assets (ROA) is -5.72% as of 2026-06-30.

What is SKIN's ROIC (return on invested capital)?

SkinHealth Systems Inc. (SKIN)'s trailing twelve month Return on Invested Capital (ROIC) is -2.00% as of 2026-06-30.

What is SKIN's EV/EBITDA?

SkinHealth Systems Inc. (SKIN)'s trailing twelve month EV/EBITDA is -118.26x as of 2026-06-30.

Wall Street's data.
Main Street's price.